Other
Cd Private Equity Fund I (CD1)
Cd Private Equity Fund I (ASX: CD1) is a micro-cap private equity fund listed on the Australian Stock Exchange since August 14, 2012. Operated out of Australia, the fund focuses on investing in private equity opportunities across various sectors in Australia and potentially the Asia-Pacific region, aiming to provide liquidity and returns to shareholders through strategic exits. Key activities involve identifying, acquiring, and managing private companies with growth potential.
Market Cap
A$14M
Shares on Issue
N/A
Price Chart
AI Analysis
Cd Private Equity Fund I currently operates with a market capitalization of A$16M, indicating its micro-cap status which inherently carries higher speculative risk. Recent performance may be volatile due to the nature of private equity investments, with valuation updates and exit news being key metrics. The fund's portfolio composition and the performance of its investee companies are crucial for shareholder returns.
Growth outlook for CD1 heavily depends on successful exits from its current investments and the ability to secure new, high-potential private equity deals. Strategic direction may involve diversification across sectors or deepening investments in promising areas, with upcoming catalysts likely including portfolio company updates, new investment announcements, or exit announcements.
Bull Case
- • Successful exit from a portfolio company at a substantial premium, significantly boosting NAV and share price.
- • Announcement of a new investment in a high-growth potential private company, enhancing portfolio attractiveness.
- • Strategic partnership or co-investment with a major player, validating CD1's investment strategy and potentially leading to more opportunities.
Bear Case
- • Unsuccessful investments leading to a write-down in portfolio value, reducing NAV and share price.
- • Difficulty in securing exits for mature portfolio companies due to market conditions, delaying returns.
- • Increased competition in the private equity space in Australia, making it harder for CD1 to source attractive deals.
Recent Announcements
Quarterly Activities Report
Highlights production updates, capital allocation priorities, and FY guidance commentary.
Investor Presentation
Strategic outlook with market positioning and growth pipeline.
FAQs
What does CD1 do?
Cd Private Equity Fund I invests in private equity opportunities across various sectors in Australia and the Asia-Pacific, seeking to provide liquidity and returns through strategic exits.
Is CD1 a good investment?
CD1 can be a good investment for those seeking exposure to private equity with the understanding of its micro-cap, speculative nature. Opportunities for high returns exist, but so do risks associated with private equity investments and market volatility.
What drives CD1's share price?
CD1's share price is driven by updates on portfolio company performance, successful exits, new investment announcements, and broader market sentiment towards private equity and the Australian market.
Key Metrics
Related Stocks
Other
ACQAcorn Capital Investment Fund Limited
A$0.95
30.1% 1Y
Acorn Capital Investment Fund Limited (ACQ) is an ASX-listed investment company (LIC) managed by specialist microcap investor Acorn Capital. The fund provides investors with access to a diversified portfolio of emerging Australian micro and small-cap companies, including both listed and unlisted entities. Its investment strategy focuses on identifying early-stage, high-growth potential businesses across various sectors.
Other
AFIAustralian Foundation Investment Company Limited
A$6.79
-4.1% 1Y
Australian Foundation Investment Company Limited (AFI) is a closed-end diversified investment trust operating solely in Australia, focusing on investing in a portfolio of mainly ASX-listed shares to provide long-term returns to shareholders through a combination of dividends and capital growth. Key holdings historically include blue-chip Australian stocks across various sectors. AFI is managed by Australian Foundation Investment Company Ltd itself, emphasizing a conservative investment approach.
Other
AIQAlternative Investment Trust
A$1.45
-1.9% 1Y
Alternative Investment Trust (ASX: AIQ) is a listed investment trust (LIT) on the Australian Securities Exchange. It provides investors with exposure to a diversified portfolio of alternative assets, primarily through investments in a global diversified portfolio of hedge funds. The trust aims to generate long-term capital growth and income for its unitholders by accessing investment strategies not typically available to retail investors.